Cargando…
Humoral response to SARS-CoV-2 infection and vaccines against COVID-19 in patients with neuromyelitis optica spectrum disorders: Impact of immunosuppressive treatment
The aim of this study was to evaluate the humoral response to the SARS-CoV-2 infection and vaccination in the NMOSD patients, treated with various immunosuppresants (ISs). Serum IgG against the complete sequence of the receptor binding domain of the spike protein was measured using ELISA SARS-CoV-2...
Autores principales: | Jovicevic, Vanja, Ivanovic, Jovana, Momcilovic, Nikola, Andabaka, Marko, Tamas, Olivera, Veselinovic, Nikola, Cujic, Danica, Gnjatovic, Marija, Mesaros, Sarlota, Pekmezovic, Tatjana, Drulovic, Jelena |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8986231/ https://www.ncbi.nlm.nih.gov/pubmed/35421782 http://dx.doi.org/10.1016/j.msard.2022.103794 |
Ejemplares similares
-
COVID-19 and vaccination against SARS-CoV-2 in patients with neuromyelitis optica spectrum disorders
por: Jovicevic, Vanja, et al.
Publicado: (2022) -
Humoral response to SARS-CoV-2 COVID-19 vaccines in patients with multiple sclerosis treated with immune reconstitution therapies
por: Drulovic, Jelena, et al.
Publicado: (2021) -
In Silico and In Vivo Analysis of IL37 in Multiple Sclerosis Reveals Its Probable Homeostatic Role on the Clinical Activity, Disability, and Treatment with Fingolimod
por: Cavalli, Eugenio, et al.
Publicado: (2019) -
Multidisciplinary rehabilitation and steroids in the management of multiple sclerosis relapses: a randomized controlled trial
por: Nedeljkovic, Una, et al.
Publicado: (2015) -
VALIDATION OF THE BRIEF INTERNATIONAL COGNITIVE ASSESSMENT FOR MULTIPLE SCLEROSIS (BICAMS) IN A LARGE COHORT OF RELAPSING-REMITTING MS PATIENTS
por: Drulović, Jelena, et al.
Publicado: (2022)